Ocean Star Technology Group Limited Overview
Ocean Star Technology Group is a Hong Kong micro-cap that, despite its technology-oriented name, is almost entirely a specialty intimate-apparel retailer. It designs, sources and sells body-shaping lingerie under the Bodibra master brand and the sub-brands June, ooobiki, Bodicare and invisi. Sales run through 8 directly operated stores in Hong Kong and Macau, one franchised counter, and a nascent mainland China distributor channel. Revenue has fallen for five years in a row, from HKD 53.4 M in FY2021 to HKD 27.0 M in FY2026. The group carries net liabilities of HKD 31.4 M, but these are dominated by HKD 41.0 M of contract liabilities from prepaid customer membership packages. After a 14-month trading suspension caused by finance-team collapse and delayed accounts, a reconstituted, largely mainland-connected board is repositioning the company as an asset-light brand owner. Its plan rests on outsourced manufacturing, franchise and distributor wholesale, and wellness cross-selling to a member base of more than 10,000 women. The equity is speculative and dilution-prone, and there is a material going-concern uncertainty.
Company's own description (latest annual results, FY2026)
In its FY2026 results, management describes the group as one of Hong Kong's leading retailers of shaping-function lingerie, with production capability in mainland China and Hong Kong. Its core activity is designing, manufacturing and selling lingerie under the "Bodibra" brand. The own-brand shaping products (bras and panties, body-shaping underwear and chest-support vests) aim to improve body appearance. The group also sells non-shaping items: breast cream, panties, nude bras, swimwear, bra straps and pads, and waist bands (paraphrased from FY2026 Results, "Business Review"). The resumption announcement of 10 September 2026 adds that the group is a brand owner and developer under Bodibra and its sub-brands June, ooobiki, Bodicare and invisi, and that it is now moving to an asset-light model.
Independent characterisation
In economic terms, Ocean Star is a prepaid-membership specialty retailer:
Revenue model: Over 99% of FY2026 revenue (HKD 26.89 M of HKD 27.00 M) is product sales recognised at a point in time. The remaining HKD 0.11 M was money-lending interest (FY2026 Results, Note 5). There is no subscription or licensing revenue in the strict sense. However, the business runs a customer-loyalty prepaid programme: Hong Kong customers buy "points packages" that give membership and tiered discounts. Packages are valid for two years and can be extended by up to two more. Cash received for these packages was HKD 29.7 M in FY2024, HKD 16.8 M in FY2025 and HKD 16.0 M in FY2026 (Resumption Announcement, Sep 2026). This prepaid cash is the group's main working-capital source. It sits on the balance sheet as contract liabilities (HKD 41.0 M at 31 Mar 2026).
Channel mix (FY2026, derived): Direct retail ≈ HKD 22.0 M. Wholesale to franchisee and distributors ≈ HKD 4.86 M, comprising about HKD 0.76 M from a franchisee and HKD 4.1 M from distributors (Resumption Announcement).
Value-chain position: Historically vertically integrated, with in-house design, own manufacturing in Hong Kong and the PRC, and own retail. Hong Kong manufacturing was retired in late 2025. Production is now fully outsourced to third-party PRC manufacturers, and the design function has been merged into procurement (Resumption Announcement). The group now keeps brand, product specification, quality control and channel management.
Customer types: Mostly retail consumers, predominantly women in Hong Kong. The company cites more than 10,000 female members built up over more than 10 years. No single customer accounted for over 10% of revenue in FY2025 or FY2026 (FY2026 Results, Note 4). B2B customers now include one franchisee (a Sha Tin Plaza retail operation since June 2025) and distributors (VNS Capital Limited and Wellness International Capital Limited) that serve PRC e-commerce and social-commerce sub-distributors.
End-markets: Hong Kong women's intimate apparel and body-shaping garments (about 95% of FY2026 revenue). Macau (about 5%). Mainland China via distributors, which is booked through Hong Kong entities.
Ancillary/legacy businesses: Money lending in Hong Kong (licensed). The loan book was fully repaid in FY2026 and nothing was outstanding at 31 Mar 2026. Aggregator profiles also mention beauty and lingerie-alteration services and a social-influencer agency platform, but these are no longer reported as separate segments.
New adjacency: Wellness cross-selling. Since 1 April 2026 the group refers its members to Tai Hung Tao International's (大鴻道) 12-week "Eastern women's posture course". It receives a guaranteed HKD 2 M per quarter plus a 20% share of tuition above 200 enrolments per quarter (Resumption Announcement).
Strategy
Stated strategy (themes from FY2026 Results and Resumption Announcement, paraphrased)
-
Consolidate the retail network. Keep only profitable or strategically important directly operated stores and renegotiate rents.
-
Asset-light production. Fully outsource manufacturing to PRC third parties. Keep design specification, brand management and quality control. Shorten the procurement cycle from about 90 to about 30 days and use supplier credit of 30, 60 or 90 days.
-
Franchise and distributor expansion. Grant brand rights and supply product to franchisees and distributors in Hong Kong and mainland China, structured as outright wholesale sales (not consignment). This shifts inventory risk downstream and turns fixed costs into variable ones.
-
Membership monetisation and cross-selling. Use the 10,000+ member base, website, member channels and Bodibra counters to sell partner wellness programmes (Tai Hung Tao) and other female-focused health products.
-
Product-mix optimisation. Move from in-house design to collaborative, outsourced design with capable manufacturers and fashion or fitness experts.
-
Cost discipline. Keep administrative and selling costs tight after the FY2026 halving of administrative expenses.
-
Pivot toward personal care, beauty and health consulting. This is implied by the board's skill set: beauty and health chain operators and B2B corporate wellness.
Initiatives register (last 24 months)
| Date | Initiative | Type | Detail / targets | Source |
|---|---|---|---|---|
| Jun 2024 | "Big health" business development | New business | Part of the June 2024 placing proceeds (≈ HKD 6.9 M on a full-placing basis) earmarked to develop a big-health business; only HKD 4.0 M net was raised | HKEX completion announcement, 24 Jun 2024 |
| Nov 2024 | Proposed rebrand to "Hainan Zhongchen Xiangxi Gold Jewelry" | Corporate identity / possible pivot to gold jewellery | Not implemented | Zhitong Finance |
| Jun 2025 | Franchise partnership (Sha Tin Plaza) | Channel | Franchisee bears local operating risk and upfront capital; FY2026 wholesale ≈ HKD 0.76 M | Resumption Announcement |
| Oct 2025 | PRC distribution: Wellness International and VNS Capital | Channel / partnership | VNS: HKD 2.5 M over 5 years plus minimum purchases of HKD 3.5 M a year; FY2026 revenue ≈ HKD 4.1 M | Resumption Announcement |
| Late 2025 | Retirement of Hong Kong manufacturing | Restructuring / asset-light | Lower staff costs and depreciation | FY2026 Results |
| Aug 2025 – Feb 2026 | Finance-function rebuild | Governance | Ledger reconstruction, outsourced accounting, cloud backups, handover manuals | Resumption Announcement |
| 24 Oct 2025 | Independent internal-control review (VAG Consultant Limited) | Governance | All identified deficiencies reported as rectified; findings announced 3 Sep 2026 | Resumption Announcement |
| 1 Apr 2026 | Tai Hung Tao wellness cross-selling | Partnership / new revenue | Guaranteed HKD 2 M per quarter (≈ HKD 8 M a year) plus 20% of tuition above 200 students per quarter | Resumption Announcement |
| 1 Jul 2026 | Cross-selling marketing campaign with a distributor | Marketing | Independent third party with its own channels | Resumption Announcement |
| Post-resumption | Equity fund-raising | Capital | Board exploring placing and/or rights issue; no plan for ≥25% theoretical dilution within 12 months (GEM Rule 10.44A); new 20% general mandate sought | Resumption Announcement; AGM circular |
Medium-term targets and guidance
Management does not give quantitative revenue or margin targets. It states an expectation that profitability will continue to improve in FY2027 (year ending 31 Mar 2027), driven by store rationalisation, distributor expansion, cross-selling and cost control (Resumption Announcement). Under GEM Rule 17.26 it also projects sufficient liquidity for 12 months. No sustainability or ESG targets with quantified commitments were identified.
Analyst note on the Tai Hung Tao deal. If the guaranteed HKD 2 M per quarter is recognised as revenue, it alone would be about 30% of FY2026 revenue at near-100% margin, enough on its own to close most of the FY2026 operating loss. The arrangement is with a counterparty that has no disclosed track record. The commercial rationale offered (a fixed fee for access to 10,000+ members) is unusual in scale relative to Ocean Star's revenue. Investors should verify recognition and cash receipt in the FY2027 interim report.
Products & Services
Product-level pricing, specifications and SKU counts are not publicly disclosed in financial filings. The catalogue below draws on the FY2026 Results, the Resumption Announcement and aggregator business descriptions.
Lingerie products segment — own brands
| Brand | Positioning / description | Key products | Target customer | Launch / latest version | Pricing model |
|---|---|---|---|---|---|
| Bodibra (core brand) | Flagship shaping-function lingerie brand, sold since the business began (2003, per aggregator) | Shaping bras, shaping panties, body-shaping underwear, chest-support vests | Hong Kong and Macau women seeking body contouring | — | Retail list price with member tier discounts; prepaid points packages valid 2 years (+2 years extension) |
| June | Sub-brand under the Bodibra umbrella | Lingerie (product detail n/d) | — | — | — |
| ooobiki | Sub-brand | Lingerie / swimwear-related (detail n/d) | — | — | — |
| Bodicare | Sub-brand, care-oriented | Likely care and accessory products (detail n/d) | — | — | — |
| invisi | Sub-brand, invisible/nude line | Nude and invisible bras (detail n/d) | — | — | — |
Non-shaping and ancillary products
| Product | Description | Source |
|---|---|---|
| Breast cream | Topical breast-care cream sold alongside lingerie | FY2026 Results |
| Panties (non-shaping) | Everyday briefs | FY2026 Results |
| Nude bras | Invisible/adhesive-style bras | FY2026 Results |
| Swimwear | Seasonal swimwear range | FY2026 Results |
| Bra straps and pads | Accessories | FY2026 Results |
| Waist bands | Waist-shaping bands | FY2026 Results |
Services
| Service | Description | Status | Source |
|---|---|---|---|
| Points-package membership programme | Prepaid packages giving membership and tiered discounts; 2-year validity, extendable by 2 years | Active; package sales falling | Resumption Announcement |
| Fitting, beauty and lingerie-alteration services | In-store services accompanying lingerie sales | Mentioned in aggregator profile; current scale n/d | Yahoo Finance |
| Franchise package | Brand rights, product supply, brand promotion and training, POS system and visual-merchandising support to franchisee (Sha Tin Plaza, since Jun 2025) | Active; FY2026 franchise wholesale ≈ HKD 0.76 M | Resumption Announcement |
| Distributor programme (PRC) | Brand rights and product supply to VNS Capital / Wellness International. VNS pays HKD 2.5 M over a 5-year term with a minimum annual purchase of HKD 3.5 M; sub-distributors and "online influencers" sell via e-commerce and flash-sale channels | Active since Oct 2025; FY2026 distributor revenue ≈ HKD 4.1 M | Resumption Announcement |
| Wellness referral (Tai Hung Tao "Eastern Women's Posture Course") | 12-week course in four modules: Eastern Awakening, Precision Sculpting, Mind-Body Healing, Image Aesthetics. Combines Huangdi Neijing concepts with Pilates and resistance training. Delivered entirely by the partner; Bodibra acts as marketing and referral channel | From 1 Apr 2026; guaranteed HKD 2 M per quarter + 20% of tuition above 200 enrolments per quarter; first payment received Aug 2026 | Resumption Announcement |
| Money lending | Unsecured loans of 1–2 years at floating rates of 17.63%–41.88% p.a. | Book fully repaid in FY2026; no outstanding loans at 31 Mar 2026 | FY2026 Results, Note 14 |
| Social-influencer agency (online platform) | KOL agency services | Legacy; not reported separately in FY2025–FY2026 | Yahoo Finance |
Financial Narrative
Basis. FY2025–FY2026 come from the audited FY2026 Results Announcement. FY2022–FY2024 income-statement items come from TipRanks (relabelled from mis-dated "Dec" columns to March fiscal years) and are cross-checked with the FY2022 Annual Report (revenue HKD 46.6 M; cost of sales HKD 12.1 M) and the June 2023 profit warning (FY2023 loss ≈ HKD 34.0 M versus the aggregator's HKD 34.72 M, a discrepancy noted). FY2022–FY2024 balance-sheet items come from HKEX interim reports (comparative audited columns) and TipRanks totals.
Income statement
Notes: - FY2025–FY2026 operating income is the reported "loss from operations". EBITDA for FY2025–FY2026 is computed as loss from operations plus PPE and ROU depreciation (FY2025 D&A HKD 7.91 M; FY2026 HKD 2.17 M). It includes FY2025 non-cash impairments of HKD 5.37 M on PPE/ROU and HKD 6.07 M on receivables and loans.
-
FY2022–FY2024 EBITDA and operating income are aggregator-defined and may not be strictly comparable.
-
FY2022–FY2024 EPS is computed from aggregator net income and weighted average shares (583.7 M, 812.9 M, 1,020 M). FY2025–FY2026 EPS is as reported.
-
FY2021 reference: revenue HKD 53.43 M, gross profit HKD 42.20 M, net income +HKD 3.70 M (TipRanks, relabelled).
Margins and growth (%)
Revenue CAGR FY2022–FY2026: -12.7% per year. FY2021–FY2026: -12.8% per year.
Expense structure FY2025–FY2026: notes and sources
Source: FY2026 Results, Notes 7, 8, 10: ### Balance sheet: notes and sources
Sources: FY2023 Interim Report (31 Mar 2022 comparatives); FY2024 Interim Report (31 Mar 2023 comparatives); FY2025 Interim Report (31 Mar 2024 comparatives); FY2026 Results (FY2025–FY2026). Total assets, liabilities and equity for FY2022–FY2024 cross-checked with TipRanks.
Cash flow
Disclosed and derivable items:
Sources: FY2026 Results, Notes 4 and 16; HKEX placing announcements; FY2023 Interim Report; Resumption Announcement.
Ratios
Inventory days are mechanically extreme because cost of sales excludes most product costs embedded in store operations, and gross margin is above 80%. Management states that the procurement cycle has shortened from about 90 to about 30 days under outsourcing (Resumption Announcement).
Commentary: trends, inflections and drivers
Revenue. Revenue has fallen every year since FY2017–FY2018 (about HKD 79 M per aggregator history) to HKD 27.0 M in FY2026. The steepest drop was FY2025 (-28.3%). Management links the decline to post-pandemic weakness in Hong Kong discretionary spending, the "northbound consumption" trend (Hong Kong residents shopping in Shenzhen and the Greater Bay Area), online shopping, consumers' reluctance to commit to lump-sum prepaid packages, and the store network shrinking from 10 to 8 (FY2026 Results; Resumption Announcement). The FY2026 decline of -8.6% is milder. It is partly cushioned by HKD 4.86 M of new wholesale revenue, which management expects to have a full-year effect only in FY2027.
Gross margin. Gross margin rose from 66% in FY2024 to 86% in FY2026. This mainly reflects classification and mix rather than pricing power. Cost of sales fell 35% in FY2026 as staff costs and materials were removed with the end of Hong Kong production. FY2025 cost of sales still included ≈ HKD 2.5 M of staff and depreciation costs, versus nil in FY2026. Management cites a gross margin "consistently above 85%" to argue that the economic burden of the HKD 41.0 M contract liabilities is only about HKD 6.2 M (Resumption Announcement).
Operating losses. FY2023–FY2025 operating losses ran at HKD 26–29 M a year on revenue of HKD 30–45 M. Drivers were store rents and depreciation, executive pay, legal and professional fees, inventory allowances, and impairments of receivables and loans. FY2026 is the inflection point. Administrative expenses halved (-HKD 18.2 M) after higher-cost management was replaced, non-recurring legal matters were settled and Hong Kong manufacturing was retired. Selling expenses fell HKD 3.6 M as stores closed. The HKD 3.18 M loan-impairment reversal flattered the result. Excluding it, the FY2026 pre-tax loss would have been about HKD 8.4 M.
Balance sheet. Equity swung from +HKD 13.2 M (FY2023) to -HKD 31.4 M (FY2026) as cumulative losses outran equity raises. The net-liability position is driven by contract liabilities: unused customer prepayments of HKD 41.0 M, down from HKD 65.2 M in FY2022. The steady decline shows that customers are consuming packages faster than new ones are sold, which is a slow liquidation of the prepaid float. Cash fell from HKD 25.6 M (FY2023) to HKD 0.5 M (FY2025), then recovered to HKD 1.7 M (FY2026) and HKD 2.6 M at 31 July 2026.
Capital structure. There is no bank debt. Lease liabilities (HKD 3.2 M) are the only interest-bearing obligations. A HKD 5.0 M facility from distributor-owner Yue Dinglong (7% p.a., 1 Oct 2025 – 31 Oct 2026) was undrawn at 31 August 2026. Funding has come from repeated, increasingly dilutive equity placings: shares rose from 480 M (April 2021) to 1,293.6 M (March 2026) and about 1,552.4 M (October 2026). Placing prices fell from about HK$0.86 (2021) to HK$0.04 (December 2024).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2025 | FY2026 |
|---|---|---|
Lingerie products revenue (HKD Mn) | 29.53 | 26.89 |
Others incl. money lending revenue (HKD Mn) | 0.00 | 0.11 |
Total revenue (HKD Mn) | 29.53 | 27.00 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2025 | FY2026 |
|---|---|---|
Lingerie products segment result (HKD Mn) | -3.70 | -5.99 |
Others segment result (HKD Mn) | -3.51 | 6.38 |
Unallocated income and expenses net (HKD Mn) | -22.80 | -5.64 |
Loss before tax (HKD Mn) | -30.02 | -5.25 |
Segment Margins & Growth (%)
| Metric | FY2025 | FY2026 | Comment |
|---|---|---|---|
Lingerie revenue YoY growth | n/d (FY2024 split n/d) | -8.9% | Weak Hong Kong consumption, northbound spending, fewer stores |
Lingerie % of group revenue | 100.0% | 99.6% | Effectively a single-segment company |
Lingerie segment margin | -12.5% | -22.3% | Segment loss widened despite cost cuts, probably reflecting inventory allowances (HKD 1.33 M) and the allocation of store costs |
Others segment result | -3.51 | +6.38 | FY2026 includes a HKD 3.18 M reversal of loan-impairment allowance after full loan recovery |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 46.59 | 44.69 | 41.17 | 29.53 | 27.00 |
Gross profit (HKD Mn) | 34.54 | 30.77 | 27.17 | 23.69 | 23.20 |
Operating income (HKD Mn) | -9.53 | -28.34 | -26.37 | -29.07 | -4.98 |
EBITDA (HKD Mn) | -5.47 | -12.12 | -14.30 | -21.16 | -2.81 |
Pre-tax income (HKD Mn) | -18.67 | -34.66 | -26.98 | -30.02 | -5.25 |
Net income (HKD Mn) | -18.80 | -34.72 | -27.16 | -30.02 | -5.25 |
Basic EPS (HK cents) | -3.22 | -4.27 | -2.66 | -2.67 | -0.41 |
Diluted EPS (HK cents) | -3.22 | -4.27 | -2.66 | -2.67 | -0.41 |
Dividends per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | -12.8 | -4.1 | -7.9 | -28.3 | -8.6 |
Gross margin (%) | 74.1 | 68.9 | 66.0 | 80.2 | 85.9 |
Operating margin (%) | -20.5 | -63.4 | -64.1 | -98.4 | -18.4 |
EBITDA margin (%) | -11.7 | -27.1 | -34.7 | -71.7 | -10.4 |
Net margin (%) | -40.4 | -77.7 | -66.0 | -101.6 | -19.4 |
Income Statement
| Metric | FY2025 | FY2026 |
|---|---|---|
Cost of sales (HKD Mn) | 5.84 | 3.80 |
Selling expenses (HKD Mn) | 12.30 | 8.73 |
Administrative and other operating expenses (HKD Mn) | 35.74 | 17.49 |
Impairment on deposits and other receivables (HKD Mn) | 3.77 | 4.52 |
Loan impairment charge or reversal (HKD Mn) | 2.30 | -3.18 |
Finance costs (HKD Mn) | 0.95 | 0.27 |
Staff costs incl directors (HKD Mn) | 18.54 | 13.80 |
Depreciation PPE plus ROU (HKD Mn) | 7.91 | 2.17 |
Auditor remuneration audit services (HKD Mn) | 0.70 | 0.65 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 95.49 | 93.39 | 59.38 | 41.21 | 36.25 |
Total liabilities (HKD Mn) | 88.89 | 80.18 | 68.45 | 67.07 | 67.62 |
Total equity (HKD Mn) | 6.60 | 13.21 | -9.07 | -25.86 | -31.37 |
Cash and bank balances (HKD Mn) | 21.90 | 25.56 | 5.05 | 0.52 | 1.73 |
Current assets (HKD Mn) | 66.88 | 63.00 | 46.58 | 39.34 | 34.03 |
Current liabilities (HKD Mn) | 81.94 | 74.17 | 66.87 | 65.46 | 66.32 |
Working capital (HKD Mn) | -15.07 | -11.17 | -20.29 | -26.12 | -32.29 |
Contract liabilities (HKD Mn) | 65.25 | 56.64 | 53.48 | 45.86 | 41.03 |
Balance Sheet — Inventories
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Inventories (HKD Mn) | not publicly disclosed (reviewed sources) | 21.14 | 16.45 | 13.28 | 12.50 |
Lease liabilities, total (HKD Mn) | 16.81 | current 10.42; non-current n/d | current 4.80; non-current n/d | 4.67 | 3.17 |
Bank / other borrowings (HKD Mn) | nil disclosed | nil disclosed | nil disclosed | nil at year end (other interest expense HKD 0.62 M in year) | nil (HKD 5.0 M facility undrawn) |
Net debt, company definition: leases − cash (HKD Mn) | -5.09 | — | — | 4.15 | 1.44 |
Goodwill and intangibles (HKD Mn) | — | 2.49 | 0.00 | 0.00 | 0.00 |
Loan receivables, net (HKD Mn) | — | 6.49 | 10.30 (6.37 current + 3.93 non-current) | 3.66 | 0.00 |
Financial assets at FVTPL (HKD Mn) | — | 3.22 | 0.69 | 1.99 | 2.01 |
Financial Analysis
| Item | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Operating cash flow | not publicly disclosed (reviewed sources) | — | — | Positive, per management ("driven by cash inflow from operating activities"); amount n/d |
Capex: PPE additions | — | — | 0.07 | 0.37 |
ROU asset additions (new leases) | — | — | 5.64 | 1.70 |
Dividends paid | 0 | 0 | 0 | 0 |
Buybacks | 0 | 0 | 0 | 0 |
Net equity raised | ≈ 42.2 (rights issue ≈ 26.0 net + placing ≈ 16.2 net) | ≈ 5.1 | ≈ 12.4 (4.0 + 8.36) | 0 |
Customer prepayments received (points packages) | — | 29.7 | 16.8 | 16.0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | n.m. (avg equity negative) | -350 | n.m. (negative equity) | — | — |
ROA (%) (net income / avg total assets) | -23.9 | -36.8 | -35.6 | -59.7 | -13.6 |
ROIC | n.m. (negative invested capital and NOPAT) | — | — | — | — |
Current ratio (x) | 0.82 | 0.85 | 0.70 | 0.60 | 0.51 |
Debt/equity | — | ≈ 0.8x (leases ÷ equity, partial) | — | — | — |
Net debt/EBITDA | n.m. (EBITDA negative) | — | — | — | — |
Interest coverage | n.m. (operating loss) | — | — | — | — |
Asset turnover (x) | 0.59 | 0.47 | 0.54 | 0.59 | 0.70 |
Inventory days (on cost of sales) | — | — | ≈ 931 | ≈ 830 | ≈ 1,200 |
Revenue by Region
| Region | FY2025 | FY2026 |
|---|---|---|
Hong Kong revenue (HKD Mn) | 26.68 | 25.59 |
Macau revenue (HKD Mn) | 2.85 | 1.41 |
PRC revenue (HKD Mn) | 0.01 | 0.00 |
Total revenue (HKD Mn) | 29.53 | 27.00 |
Geographic Revenue
| Region | FY2026 YoY growth | FY2026 % of revenue | Commentary |
|---|---|---|---|
Hong Kong | -4.1% | 94.8% | Includes wholesale sales to PRC distributors (booked in Hong Kong), which masks a steeper fall in Hong Kong retail. Excluding ≈ HKD 4.86 M of wholesale, HK retail was ≈ HKD 20.7 M (derived) |
Macau | -50.6% | 5.2% | Fastest-declining region; one store in the network as of Feb 2025 |
PRC (direct) | -100% | 0.0% | Direct PRC retail revenue ceased; PRC exposure now runs through distributors |
Share Count (M) and Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Shares in issue at FY end (M) | 630.0 | 1,010.0 | 1,036.3 | 1,293.6 | 1,293.6 |
Net equity raised in FY (HKD Mn) | 41.0 | 42.2 | 5.1 | 12.4 | 0.0 |
Share Price History
| Date | Price (HKD) | Context | Source |
|---|---|---|---|
13 Jul 2017 | 0.400 | IPO price | etnet |
| 2021 | ≈ 0.86 | Implied 2021 placing price | FY2023 Interim (derived) |
Feb–Mar 2023 | 0.15 | Placing price | HKEX |
Nov 2023 | 0.20 | Placing price | HKEX |
≈ Apr 2024 | 0.135 (52-week range 0.101–0.435) | Yahoo snapshot | Yahoo Finance |
29 May 2024 | 0.094 | Close on placing date | HKEX |
25 Nov 2024 | 0.033 | Close on placing date | HKEX |
30 Jun 2025 / last before suspension | 0.039 | Pre-suspension; market cap ≈ HKD 50.5 M | Google Finance; TipRanks |
9 Oct 2026 | 0.031 (nominal; -20.5% vs 0.039) | Post-resumption quote | etnet |
Share Price & Returns
| Horizon | Approximate return | Basis |
|---|---|---|
1-year (Oct 2025 – Oct 2026) | ≈ -20% | Suspended most of the period; HK$0.039 → HK$0.031 |
3-year (Oct 2023 – Oct 2026) | ≈ -85% | — |
5-year (Oct 2021 – Oct 2026) | ≈ -95% or worse | — |
Since IPO (Jul 2017) | ≈ -92% | HK$0.40 → HK$0.031 |
Valuation Multiples
| Multiple | Ocean Star | Comment |
|---|---|---|
Market cap | ≈ HKD 48.1 M | — |
Enterprise value | ≈ HKD 49.6 M | — |
EV/Sales (FY2026) | ≈ 1.8x | HKD 49.6 M / HKD 27.0 M |
Analyst Conclusions
Management guidance
Management offers no numeric guidance. It expects profitability to keep improving in FY2027, driven by:
-
retaining only profitable or strategic stores,
-
franchise and distributor wholesale, whose full-year effect starts in FY2027,
-
cross-selling through the member network, including Tai Hung Tao's guaranteed HKD 2 M per quarter, and
-
strict cost control (Resumption Announcement).
The company projects 12 months of sufficient liquidity without counting new equity, but says it is actively exploring placings or rights issues.
Consensus
There is no sell-side coverage, so no consensus exists.
Bull case (grounded in data)
-
Fee income could flip the P&L. If the Tai Hung Tao guarantee is recognised in full (≈ HKD 8 M a year at near-100% margin), it alone exceeds the FY2026 pre-tax loss of HKD 5.2 M.
-
A lower cost base gives operating leverage. Administrative and selling costs fell by HKD 21.8 M in FY2026. With an 86% gross margin, flat revenue plus the full-year effect of wholesale (VNS minimum of HKD 3.5 M a year) could carry the group to breakeven in FY2027.
-
The balance sheet is less bad than it looks. HKD 41.0 M of the HKD 67.6 M in liabilities is a non-cash prepayment obligation. Management estimates its cash cost of fulfilment at about HKD 6.2 M. Excluding this, the "economic" net liability position is close to neutral.
Bear case (grounded in data)
-
The core business keeps shrinking. Revenue has fallen for five straight years (-12.7% CAGR). The lingerie segment loss widened to HKD 6.0 M. Prepaid package receipts fell 46% in two years, so the cash float is running off.
-
Going concern and dilution. Cash was only HKD 1.7–2.6 M against HKD 66.3 M of current liabilities. The auditor flagged material uncertainty. The share count has more than tripled since 2021, and another 20% was apparently issued in autumn 2026 at undisclosed terms.
-
Governance and counterparty risk. Two suspensions in three years and near-total board turnover. The new revenue rests on small, recently formed private counterparties (VNS, Wellness International, Tai Hung Tao), and the lender is also a distributor owner.
Catalysts and monitorables (next 12 months)
- Terms, placees and use of proceeds of the ≈ 258.7 M-share issue (Sep–Oct 2026); Liu Suying's role and intentions as the new 11% holder.
FY2027 interim results (to 30 Sep 2026, due ≈ Nov 2026): first evidence of Tai Hung Tao fees (recognition and cash), wholesale run-rate, and segment profitability.
-
Renewal or drawdown of the HKD 5.0 M facility expiring 31 Oct 2026.
-
Store count (8) and any further closures; trend in new prepaid-package sales.
-
Auditor change: confirm whether World Link CPA replaced McMillan Woods, and the reasons.
-
Expiry of the Share Option Scheme (June 2027) and any new incentive scheme.
-
Any revival of the gold-jewellery rename or a pivot into other businesses (beauty/health, B2B wellness).
-
Outcome of the small-claims secretarial-fee action (≈ HKD 0.2 M, November 2026).
-
Timeliness of all GEM periodic filings, as a test of the remediated finance function.
Analyst verdict
Ocean Star Technology Group is, in substance, a distressed niche lingerie retailer emerging from a 14-month trading suspension. It is not a technology company. The FY2026 numbers show a real but narrow turnaround. The loss fell from HKD 30.0 M to HKD 5.2 M, but almost all of the improvement came from removing corporate overhead (administrative costs halved), exiting Hong Kong manufacturing and a one-off HKD 3.2 M loan-impairment reversal. Underlying lingerie demand did not improve: revenue fell again, the lingerie segment's loss widened, and customers are buying far fewer prepaid packages than two years ago. The balance sheet carries negative equity of HKD 31.4 M and only a few million dollars of cash. It is held together by the float of customer prepayments and by repeated equity issuance at ever-lower prices.
The new board, drawn largely from mainland beauty, health and supply-chain networks, has a coherent plan on paper: outsource production, franchise and distribute, and monetise the membership through wellness referrals. Most of the near-term upside rests on one agreement, the Tai Hung Tao guaranteed fee. That fee is large relative to the company, recent, and with a counterparty whose economic capacity is not disclosed. Its conversion into recognised, cash-backed revenue in the FY2027 interim report is the single most important data point.
At an EV of about HKD 50 M (≈ 1.8x sales) for a business with no sustained profitability, a material-uncertainty audit opinion and a history of serial dilution, the shares are priced as an option on the turnaround and on the listing platform itself. Governance credibility has to be rebuilt through several clean, on-time reporting cycles. Assessment: highly speculative. The base case is continued cash-constrained operations, with downside from GEM compliance and funding risk.
End of dossier. All figures are in HKD unless stated; FY ends 31 March. "n/d" = not publicly disclosed in the sources reviewed; "n.m." = not meaningful. Aggregator-derived FY2022–FY2024 figures should be reconciled to the full annual reports before institutional use.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Background (as disclosed) | Source |
|---|---|---|---|---|
Jiao Dejun (矯德君) | Chairman and Executive Director; focus on supply chain and market expansion | 1 Dec 2025 | Master's degree in mechanical manufacturing process and equipment (Dalian Railway Institute, now Dalian Jiaotong University); Master's in international marketing (Ascencia Business School, Paris). Executive director of Zhongxian Smart Home Holdings (GEM: 8395); director of Kaishite Smart Technology (Dongguan), Shenzhen Linghang Bio Supply Chain, Dalian Jubo Precision Mould | Resumption Announcement |
Hu Yanhui (胡彥會) | Executive Director and CEO; focus on growth and channel strategy (PRC distributors) | 4 Nov 2025 | Planning, resource allocation and marketing focus; further detail n/d | Resumption Announcement |
Sun Tian (孫天) | Executive Director; focus on retail and franchise operations. Chairman until Dec 2025 | Joined 2024 or earlier (chairman by Nov 2024) | Entrepreneur in beauty and health consulting; founded a PRC beauty/health group (strategy and development lead Sep 2009 – Oct 2019); experience scaling beauty/health chains to 2,000+ outlets | Resumption Announcement; FY2025 Interim Report |
Xu Xue (許學) | Executive Director; focus on B2B and wellness integration | ≤ Jul 2021 (longest-serving director) | Adviser to the Jian Ai Hong Kang moxibustion chain (500 stores) and the Yongbao Longevity medical chain (20 sites); 20+ years in manufacturing and electronics; former ED of Republic Healthcare (GEM: 8357) | Resumption Announcement; 2021 announcements |
Liu Jiawei (劉嘉威) | Executive Director; focus on systems and efficiency (IT, logistics) | 4 Nov 2025 | IT systems, logistics and cross-functional management | Resumption Announcement |
Tong Zhu (佟鑄) | Independent Non-executive Director; Audit Committee member | ≤ Feb 2023 | — | FY2026 Results |
Hong Sze Lung (康仕龍) | INED; Audit Committee Chairman | 25 Aug 2025 | — | Resumption Announcement; FY2026 Results |
Li Tiejing (李鐵靜) | INED; Audit Committee member | 1 Dec 2025 | — | Resumption Announcement |
Li Hongwei (李宏偉) | INED | 1 Dec 2025 | — | Resumption Announcement |
Executive Leadership Team
| Name | Role | Appointed | Background | Source |
|---|---|---|---|---|
Peng Zhengdong | Chief Operating Officer | Jun 2026 | 30+ years in fashion retail and brand management; senior roles at New Balance, Metersbonwe, Sunshine Fashion and Pink Mary; director and GM of a Shanghai brand-strategy consultancy | Resumption Announcement |
Flora Tang | Senior retail sales/operations professional | 2025–2026 | 14+ years managing sales teams, mainly in lingerie and personal care | Resumption Announcement |
Lee Hiu Tung (李曉彤) | Joint Company Secretary (etnet lists as Company Secretary) | 25 Aug 2025 | — | Resumption Announcement; etnet |
CFO | Finance Director recruited Aug 2025 – Jan 2026 (name n/d) | — | — | Resumption Announcement |
Board & Management Changes
| Date | Change | Source |
|---|---|---|
Jul–Sep 2021 | Board: Tam Chak Chi (譚澤之, ED), Xu Xue (ED); INEDs Yuen Siu Sin (袁小茜), Tang Kwok Wang (鄧國宏), Tang Yiu Kei (鄧耀基) | 2021 name-change announcements |
Feb–Aug 2023 | Cheng Sze Hu (鄭思虎) Chairman and ED; Tam Chak Chi, Xu Xue EDs; Chen Lizhu ED by Aug 2023; INEDs Lai Kim Fung (厲劍峰), Tang Yiu Kei, Tong Zhu | 2023 announcements |
29 Jul 2024 | Chiu Chi Kiu (趙之翹) resigns as ED, company secretary, CFO and compliance officer; Cheng Chak Yan (鄭作欣) appointed ED, company secretary and CFO | Resumption Announcement |
21 Oct 2024 | Cheng Chak Yan resigns | Resumption Announcement |
By 29 Nov 2024 | Sun Tian Chairman; board: Sun Tian, Chen Lizhu, Xu Xue, Yang Xueling (EDs); INEDs Lai Kim Fung, Tang Yiu Kei, Tong Zhu | FY2025 Interim Report |
8 Nov 2024 | Lee Kun Yin (李冠賢) appointed CFO and company secretary | Resumption Announcement |
25 Nov 2024 | Choi Pun Lap (蔡本立) appointed joint company secretary | Resumption Announcement |
18 Mar 2025 | Chen Lizhu resigns as CEO (remains ED) | Resumption Announcement |
11 Apr 2025 | Choi Pun Lap removed as joint company secretary (cost reasons) | Resumption Announcement |
By 2 Jul 2025 | Board expanded: EDs Sun Tian, Chen Lizhu, Xu Xue, Yang Mingyuan, Zhou Ying, Yang Xueling; NED Shi Zhu; INEDs Lai Kim Fung, Tong Zhu, Han Zhenghai, Mo Li | Suspension announcement |
10 Jul 2025 | INED Mo Li resigns | Resumption Announcement |
25 Aug 2025 | Hong Sze Lung (INED) and Lee Hiu Tung (joint company secretary) appointed | Resumption Announcement |
15 Sep 2025 | CFO Lee Kun Yin resigns | Resumption Announcement |
15 Oct 2025 | Shi Zhu (NED), Zhou Ying, Chen Lizhu, Yang Mingyuan (EDs) and Han Zhenghai (INED) retire at the AGM | Resumption Announcement |
4 Nov 2025 | Hu Yanhui (ED and CEO) and Liu Jiawei (ED) appointed | Resumption Announcement |
1 Dec 2025 | Jiao Dejun (ED, later Chairman), Li Hongwei and Li Tiejing (INEDs) appointed; Lai Kim Fung (INED) retires | Resumption Announcement |
19 Dec 2025 | Yang Xueling resigns as ED | Resumption Announcement |
Jun 2026 | Peng Zhengdong appointed COO | Resumption Announcement |
Major Shareholders
| Holder | Shares | % of issued | As-of date | Source |
|---|---|---|---|---|
Liu Suying | 170,730,000 | 11.00% (of 1,552.4 M) | 6 Oct 2026 | etnet (SDI) |
Capital Realm Financial Holdings Group Ltd (HKEX: 0204) | 125,257,500 | 8.07% (of 1,552.4 M); 9.68% of 1,293.6 M as at 20 Jun 2025 | 6 Oct 2026 | etnet |
Global Succeed Group Limited (historical controlling shareholder; 50/50 beneficial ownership per 2022 GEM information sheet) | n/d (no longer listed as substantial) | — | 2021–2022 | HKEX information sheets |
Directors' interests | Not disclosed in reviewed sources | — | — | — |
Public float | ≥ 25% maintained | — | 31 Mar 2026 | FY2026 Results |
Competitive Landscape
Key Competitors
| Competitor | Listing | Segment overlap | Latest revenue (verified where stated) | Positioning vs Ocean Star |
|---|---|---|---|---|
Aimer Co., Ltd. | SSE: 603511 | Premium women's intimate apparel, mainland China | RMB 3,094 M (FY2025, YE Dec) | Roughly 100× larger; strong PRC brand; the obvious benchmark for the distributor push into China |
Cosmo Lady (China) Holdings | HKEX: 2298 | Mass-market intimate apparel, PRC; e-commerce-led | RMB 1,436 M (H1 2025); profitable (RMB 57.8 M attributable) | Market leader in PRC women's intimate wear; e-commerce GMV of RMB 4.3 bn+ (2025 AR) |
Wacoal Holdings | TSE: 3591 | Premium lingerie incl. shaping; HK department-store presence | — | Global premium brand with direct overlap in Hong Kong shaping bras |
Triumph International | Private | Lingerie incl. shapewear; HK and Macau retail | — | Strong Hong Kong mall presence |
Victoria's Secret & Co. | NYSE: VSCO | Lingerie, beauty; Hong Kong stores | — | Global fashion lingerie and beauty cross-sell |
Fast Retailing (Uniqlo innerwear) | TSE: 9983 | Value innerwear, wireless bras | — | Price and convenience competitor |
Ubras | Private (PRC) | Size-free wireless bras, e-commerce | — | Digital-native competitor in the PRC channels Ocean Star targets |
Neiwai (内外) | Private (PRC) | Comfort lingerie, e-commerce and retail | — | Premium-comfort positioning |
Shapewear specialists and beauty/slimming centres in Hong Kong (e.g., Marie France Bodyline–type operators) | Various / private | Body contouring via prepaid service packages | — | Compete for the same prepaid "body-shaping" wallet |
Regina Miracle International | HKEX: 2199 | Intimate-apparel manufacturing (supplier side) | — | Potential outsourcing partner rather than a retail competitor |
“—” = not publicly disclosed.
Peer Comparison FY2026
| Metric | Ocean Star (FY2026, HKD) | Aimer (FY2025, MYR Bn) | Cosmo Lady (H1 2025, MYR Bn) |
|---|---|---|---|
Revenue | HKD 27.0 M | RMB 3,094 M | RMB 1,436 M (half year) |
Revenue growth | -8.6% | -2.2% | n/d in reviewed source |
Gross margin | 85.9% | ≈ 65.4% | — |
Operating margin | -18.4% | ≈ 4.1% | — |
Net margin | -19.4% | — | ≈ 4.0% (attributable) |
R&D intensity | Not disclosed (no line item) | ≈ 3.7% | — |
Recent Developments
--



